| BioCommerce Data Ltd Profile to follow shortly. |
 |
| Biotechnology Investment Today Biotechnology Investment Today is a quarterly review journal for stakeholders in the biotechnology industry. The magazine covers therapeutic and technology sectors within the industry as well as critical operational and financing issues that directly affect company and shareholder value. Topics covered in recent issues include: Cancer Therapeutics, Pharmacogenomics, M&A, Capital Markets and Pathways to Market. The magazine also covers emerging markets and in 2002 will review Australia, Israel, Singapore and Japan. Biotechnology Investment Today is supported by a global seminar and investor network series with events held regularly in the US and Europe. |
 |
| BioVenture View BioVenture View is the definitive news source detailing all the latest developments in biotechnology worldwide. Focusing almost exclusively on developmental-stage, innovative, privately held biotechs, BioVenture View has the inside line on tomorrow's big names and the key pressures private firms face. It is essential reading for anyone involved in the sector and will provide you with the analysis, facts and business intelligence you need to succeed in this increasingly competitive environment. Written by a team of experienced science and business journalists, you know you can rely on BioVenture View for its high-quality, authoritative coverage. |
 |
| BioWorld Today BioWorld Today, the newspaper of record for the biotechnology industry, is read by thousands of biotechnology professionals worldwide for its hard-hitting, objective news reporting. BioWorld Today is delivered by e-mail and fax every business morning, and is also found exclusively online at www.BioWorld.com. BioWorld’s web site has been internationally recognized as the most comprehensive resource for strategic biotechnology news and information available today. In addition to original daily news reporting, BioWorld offers an extensive searchable database with more than 13 years of biotechnology archives. This site is not only a great source for insightful, up-to-the-minute news coverage, but a veritable library of information on the developments of the industry as well. With a quick search, BioWorld subscribers have instant access to a wealth of biotechnology market intelligence from every biotech hotspot around the globe. BioWorld does not post press releases, but rather uses information that is researched and written by the top business and science reporters in the industry. With nearly 20 writers spread throughout eight countries, BioWorld covers news on public companies and hard-to-find information on private companies. Our seasoned reporters get the inside scoop on what’s happening within the corporate walls, on regulatory issues in Washington and elsewhere, and on scientific breakthroughs worldwide. This news coverage of the biotechnology industry is 100% original and only available at BioWorld! BioWorld Products:
BioWorld Today |
 |
| BusinessWire Distributing Your Biotechnology News via Business Wire BioWire , developed by Business Wire in conjunction with Mary Ann Liebert Inc., publisher of Genetic Engineering News, delivers your biotechnology news to a specialized list of industry trades, journals and reporters, as well as key biotechnology analysts and investment professionals. Business Wire has direct news feeds into thousands of media, investor and online destinations, Web portals and sites via our multi-channel proprietary news networks. As a trusted news source for more than four decades, reporters and analysts rely on Business Wire to deliver timely news, targeted to their needs. Use BioWire to issue a single news announcement or as part of your ongoing communications strategy. Select the geographic media circuit that best meets your needs and we'll make sure appropriate trades and journals, investment professionals and Web portals also receive your news - quickly and in their preferred method. And as appropriate, we automatically include distribution into newsroom computers at all important financial news media including Dow Jones, AP and Reuters. For additional information visit www.businesswire.com
|
 |
| The Journal of Biolaw & Business Profile to follow shortly. |
 |
| Nature Biotechnology Nature Biotechnology is the premier peer-reviewed monthly of biotechnology, providing reviews and research reports on the research and technologies that drive biotechnological innovation wherever they are applied – in the biotechnology, pharmaceutical, agricultural and environmental industries. With an impact factor of 12.822*, Nature Biotechnology is rated number one among primary journals in its field. Simply visit www.nature.com/naturebiotechnology for more information. *Thomson ISI, PA, USA, 2002 |
 |
| Nature Reviews Drug Discovery Nature Reviews Drug Discovery is a monthly review journal that publishes authoritative, peer-reviewed articles by leaders in the field – providing a complete overview of the drug discovery and development arena, from disease mechanisms and chemistry, through to clinical development and regulatory issues. The journal, which integrates academia and industry, features cutting edge Review articles, Highlights of the latest primary papers, as well as Opinion articles and historical Perspectives. For more information simply visit www.nature.com/reviews/drugdisc |
 |